Erratum: Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer (Proceedings of the National Academy of Sciences of the United States of America (9862-9867) 110 (2013) DOI: 10.1073/pnas.1307575110);Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 24, 2013, Pages 9862-9867

  Hu, Bo ^a   Elinav, Eran ^a,b   Huber, Samuel ^a,c   Strowig, Till ^a   Hao, Liming ^a   Hafemann, Anja ^a   Jin, Chengcheng ^a   Eisenbarth, Stephanie C ^a   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

ASC; Colon cancer; Microflora

Indexed keywords

INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 6; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR FAMILY PYRIN DOMAIN CONTAINING 6; RANTES; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIUM CELL; INFLAMMATION; MICROFLORA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

MUS;

EID: 84878971321     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1311700110     Document Type: Erratum

References (47)

1. Weir HK, et al. (2003) Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95(17):1276-1299. (Pubitemid 37160862)
2. Jess T, Rungoe C, Peyrin-Biroulet L (2012) Risk of colorectal cancer in patients with ulcerative colitis: A meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 10(6):639-645.
3. Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 48(4):526-535. (Pubitemid 32234798)
4. Popivanova BK, et al. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118(2):560-570. (Pubitemid 351206546)
5. Becker C, et al. (2004) TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21(4):491-501. (Pubitemid 39370505)
6. Bollrath J, et al. (2009) gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15(2):91-102.
7. Grivennikov S, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15(2):103-113.
8. Huber S, et al. (2012) IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491(7423):259-263.
9. Greten FR, et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118(3):285-296. (Pubitemid 39061110)
10. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883-899.
11. Henao-Mejia J, et al. (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482(7384):179-185.
12. Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361(9356):512-519. (Pubitemid 36173720)
13. Wen L, et al. (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455(7216):1109-1113.
14. Wang Z, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57-63.
15. Gionchetti P, et al. (2003) Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology 124(5):1202-1209. (Pubitemid 36531796)
16. Frank DN, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104(34):13780-13785. (Pubitemid 350003397)
17. Davis CD, Milner JA (2009) Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 20(10):743-752.
18. Goodwin AC, et al. (2011) Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci USA 108(37): 15354-15359.
19. Abdulamir AS, Hafidh RR, Abu Bakar F (2011) The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res 30:11.
20. Arthur JC, et al. (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120-123.
21. Elson CO, et al. (2005) Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206:260-276. (Pubitemid 41105175)
22. Hambly RJ, Rumney CJ, Fletcher JM, Rijken PJ, Rowland IR (1997) Effects of high- and low-risk diets on gut microflora-associated biomarkers of colon cancer in human flora-associated rats. Nutr Cancer 27(3):250-255. (Pubitemid 27161522)
23. Muegge BD, et al. (2011) Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332(6032):970-974.
24. Reddy BS, el-Bayoumy K, Louis YM (1985) Germfree animal as a tool to study role of gut microflora and nutrition in cancer. Prog Clin Biol Res 181:293-296.
25. Reddy BS, Weisburger JH, Narisawa T, Wynder EL (1974) Colon carcinogenesis in germ-free rats with 1,2-dimethylhydrazine and N-methyl-n′-nitro-N-nitrosoguanidine. Cancer Res 34(9):2368-2372.
26. Fukata M, Abreu MT (2010) Microflora in colorectal cancer: A friend to fear. Nat Med 16(6):639-641.
27. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140(6):821-832.
28. Strowig T, Henao-Mejia J, Elinav E, Flavell R (2012) Inflammasomes in health and disease. Nature 481(7381):278-286.
29. Martinon F, Burns K, Tschopp J (2002) The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10(2):417-426. (Pubitemid 35007355)
30. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453(7198):1122-1126. (Pubitemid 351871731)
31. Mariathasan S, et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440(7081):228-232. (Pubitemid 43372102)
32. Jin C, et al. (2011) NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc Natl Acad Sci USA 108(36):14867-14872.
33. Dupaul-Chicoine J, et al. (2010) Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32(3):367-378.
34. Elinav E, et al. (2011) NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145(5):745-757.
35. Allen IC, et al. (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 207(5):1045-1056.
36. Zaki MH, et al. (2010) The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32(3):379-391.
37. Hu B, et al. (2010) Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci USA 107(50):21635-21640.
38. Chen GY, Liu M, Wang F, Bertin J, Núñez G (2011) A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol 186(12):7187-7194.
39. Bauer C, et al. (2010) Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 59(9):1192-1199.
40. Allen IC, et al. (2012) NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity 36(5):742-754.
41. Zaki MH, et al. (2011) The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20(5):649-660.
42. Papanikolaou A, et al. (1998) Initial levels of azoxymethane-induced DNA methyl adducts are not predictive of tumor susceptibility in inbred mice. Toxicol Appl Pharmacol 150(1):196-203. (Pubitemid 28288435)
43. Mariathasan S, et al. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430(6996):213-218. (Pubitemid 38902430)
44. Miao EA, et al. (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7(6):569-575. (Pubitemid 43797337)
45. Sutterwala FS, Flavell RA (2009) NLRC4/IPAF: A CARD carrying member of the NLR family. Clin Immunol 130(1):2-6.
46. Mihara M, et al. (2004) Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis. J Rheumatol 31(6):1132-1138. (Pubitemid 38715889)
47. Becker C, Fantini MC, Neurath MF (2006) High resolution colonoscopy in live mice. Nat Protoc 1(6):2900-2904.